Increased plasma neurotensin concentrations in patients with Parkinson's disease
about
Structure of the agonist-bound neurotensin receptorStructure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coliBright fluorescence monitoring system utilizing Zoanthus sp. green fluorescent protein (ZsGreen) for human G-protein-coupled receptor signaling in microbial yeast cellsModulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipidDiverse roles of neurotensin agonists in the central nervous systemTransient and stable expression of the neurotensin receptor NTS1: a comparison of the baculovirus-insect cell and the T-REx-293 expression systems.MiRNA mimic screen for improved expression of functional neurotensin receptor from HEK293 cellsG Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro.Analysis of argentinated peptide complexes using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: Peptide = oxytocin, arg(8) -vasopressin, bradykinin, bombesin, somatostatin, neurotensin.Structural dynamics and thermostabilization of neurotensin receptor 1The role of neurotensin in central nervous system pathophysiology: what is the evidence?Biophysical characterization of membrane proteins in nanodiscs.Calpain-mediated signaling mechanisms in neuronal injury and neurodegenerationCross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergicsNeurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture.In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist.
P2860
Q27674395-487A4660-5BA7-4655-AA67-8144758EBCD1Q27681431-5D66D1A2-25B6-40C4-B011-E7FBECC54633Q28536254-4DFCA1DD-C063-4054-8CDA-D7C9C0CE670EQ28584277-7950BDC9-EF02-4DCA-8ACB-65FFE24FBA55Q30456105-5F9B9CBB-8807-4E25-A5CD-177597882BAFQ34733947-6EB2EDA1-8A0F-419E-A23E-EA9EABD32CE5Q35560091-9D06A4BD-A63C-4AA4-AFA1-580D57EF447CQ35881875-E5DE572B-3E30-46CD-85AA-79A67889A6CBQ36016163-2B3E5419-63EF-4665-945B-4BA5DB31BAC7Q36044571-084368CC-D979-425D-A3E4-456CAB1EE687Q36544566-9C5F4965-2B06-435B-9614-D17A57DAE96AQ36718332-60B0AC8A-837A-445A-B955-2088AC1848ABQ37237452-B3170489-04BE-489E-8497-3089D6D5A283Q42186802-4C0B77AB-37E6-450D-AC7B-A580261304F2Q44224256-67BA3221-CBA9-4906-AA34-FBCDF5852399Q51594469-BB172DA7-E24F-496C-951D-C622ACA2DEC7
P2860
Increased plasma neurotensin concentrations in patients with Parkinson's disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@ast
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@en
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@nl
type
label
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@ast
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@en
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@nl
prefLabel
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@ast
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@en
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@nl
P2093
P356
P1476
Increased plasma neurotensin concentrations in patients with Parkinson's disease
@en
P2093
A M Lhiaubet
M Vidailhet
R M Schimpff
P304
P356
10.1136/JNNP.70.6.784
P407
P577
2001-06-01T00:00:00Z